Tamara Pringsheim

Summary

Affiliation: University of Calgary
Country: Canada

Publications

  1. pmc Incidence and prevalence of multiple sclerosis in Europe: a systematic review
    Elaine Kingwell
    Department of Internal Medicine, University of Manitoba, Winnipeg, Canada
    BMC Neurol 13:128. 2013
  2. pmc Prevalence of neurological conditions across the continuum of care based on interRAI assessments
    Oana Danila
    School of Public Health and Health Systems, University of Waterloo, Waterloo, Canada
    BMC Health Serv Res 14:29. 2014
  3. pmc Rizatriptan for the acute treatment of migraine: Consistency, preference, satisfaction, and quality of life
    Farnaz Amoozegar
    Calgary Headache Assessment and Management Program, Department of Clinical Neurosciences, University of Calgary, Calgary, AB, Canada
    Patient Prefer Adherence 3:251-8. 2009
  4. pmc Prenatal risk factors for Tourette Syndrome: a systematic review
    Ting Kuang Chao
    Department of Clinical Neurosciences, University of Calgary, Calgary, Canada
    BMC Pregnancy Childbirth 14:53. 2014
  5. doi request reprint Social behavior and comorbidity in children with tics
    Tamara Pringsheim
    Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada Electronic address
    Pediatr Neurol 49:406-10. 2013
  6. doi request reprint Tourette syndrome and other tic disorders of childhood
    Pringsheim Tamara
    Department of Clinical Neurosciences and Pediatrics, University of Calgary, Alberta Children s Hospital, Calgary, Canada Electronic address
    Handb Clin Neurol 112:853-6. 2013
  7. ncbi request reprint Second-generation antipsychotics for the treatment of disruptive behaviour disorders in children: a systematic review
    Tamara Pringsheim
    Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada
    Can J Psychiatry 57:722-7. 2012
  8. ncbi request reprint Canadian guidelines for the evidence-based treatment of tic disorders: pharmacotherapy
    Tamara Pringsheim
    Department of Clinical Neurosciences and Pediatrics, University of Calgary, Calgary, Alberta
    Can J Psychiatry 57:133-43. 2012
  9. doi request reprint The incidence and prevalence of Huntington's disease: a systematic review and meta-analysis
    Tamara Pringsheim
    Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada
    Mov Disord 27:1083-91. 2012
  10. doi request reprint The pharmacoepidemiology of antipsychotic medications for Canadian children and adolescents: 2005-2009
    Tamara Pringsheim
    Department of Clinical Neurosciences and Pediatrics, University of Calgary, Calgary, Canada
    J Child Adolesc Psychopharmacol 21:537-43. 2011

Collaborators

Detail Information

Publications21

  1. pmc Incidence and prevalence of multiple sclerosis in Europe: a systematic review
    Elaine Kingwell
    Department of Internal Medicine, University of Manitoba, Winnipeg, Canada
    BMC Neurol 13:128. 2013
    ..This study aimed to systematically review European studies of incidence and prevalence of MS and to provide a quantitative assessment of their methodological quality...
  2. pmc Prevalence of neurological conditions across the continuum of care based on interRAI assessments
    Oana Danila
    School of Public Health and Health Systems, University of Waterloo, Waterloo, Canada
    BMC Health Serv Res 14:29. 2014
    ....
  3. pmc Rizatriptan for the acute treatment of migraine: Consistency, preference, satisfaction, and quality of life
    Farnaz Amoozegar
    Calgary Headache Assessment and Management Program, Department of Clinical Neurosciences, University of Calgary, Calgary, AB, Canada
    Patient Prefer Adherence 3:251-8. 2009
    ..The published clinical trials included in this systematic review are subject to bias due to the open-label nature of preference trials and the doses chosen for comparison in head-to-head trials...
  4. pmc Prenatal risk factors for Tourette Syndrome: a systematic review
    Ting Kuang Chao
    Department of Clinical Neurosciences, University of Calgary, Calgary, Canada
    BMC Pregnancy Childbirth 14:53. 2014
    ..A systematic review and qualitative analysis were performed to provide a broad view of the association between pre- and perinatal factors and TS...
  5. doi request reprint Social behavior and comorbidity in children with tics
    Tamara Pringsheim
    Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada Electronic address
    Pediatr Neurol 49:406-10. 2013
    ..To examine the characteristics of children with coexisting tics and autism spectrum disorder and determine if children with tics have deficits in social behavior...
  6. doi request reprint Tourette syndrome and other tic disorders of childhood
    Pringsheim Tamara
    Department of Clinical Neurosciences and Pediatrics, University of Calgary, Alberta Children s Hospital, Calgary, Canada Electronic address
    Handb Clin Neurol 112:853-6. 2013
    ..As treatment for tics does not alter the natural history of the disorder, it is only recommended if the tics are causing disability. Effective treatments to suppress tics include α-adrenergic agonists and antipsychotic medications...
  7. ncbi request reprint Second-generation antipsychotics for the treatment of disruptive behaviour disorders in children: a systematic review
    Tamara Pringsheim
    Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada
    Can J Psychiatry 57:722-7. 2012
    ..Increases are mainly attributable to treatment of disruptive behaviour disorders (DBDs). Our objective was to review the evidence regarding the efficacy of SGAs for DBDs in youth...
  8. ncbi request reprint Canadian guidelines for the evidence-based treatment of tic disorders: pharmacotherapy
    Tamara Pringsheim
    Department of Clinical Neurosciences and Pediatrics, University of Calgary, Calgary, Alberta
    Can J Psychiatry 57:133-43. 2012
    ..However, when tics are more distressing and interfering, the need for tic suppression to improve quality of life is stronger, and patients and clinicians may be more willing to accept the risks of pharmacotherapy...
  9. doi request reprint The incidence and prevalence of Huntington's disease: a systematic review and meta-analysis
    Tamara Pringsheim
    Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada
    Mov Disord 27:1083-91. 2012
    ..HD is a devastating neurodegenerative disorder with a higher prevalence in Europe, North America, and Australia than in Asia. The difference in prevalence of this genetic disorder can be largely explained by huntingtin gene haplotypes...
  10. doi request reprint The pharmacoepidemiology of antipsychotic medications for Canadian children and adolescents: 2005-2009
    Tamara Pringsheim
    Department of Clinical Neurosciences and Pediatrics, University of Calgary, Calgary, Canada
    J Child Adolesc Psychopharmacol 21:537-43. 2011
    ..To describe the frequency and trends of use of antipsychotics in Canadian children and adolescents from 2005 to 2009...
  11. ncbi request reprint The pharmacoepidemiology of antipsychotics for adults with schizophrenia in Canada, 2005 to 2009
    Tamara Pringsheim
    Department of Clinical Neurosciences, University of Calgary, Alberta
    Can J Psychiatry 56:630-4. 2011
    ..To describe the frequency and trends in the use of antipsychotics for adults with schizophrenia in Canada from 2005 to 2009...
  12. pmc Evidence-based recommendations for monitoring safety of second generation antipsychotics in children and youth
    Tamara Pringsheim
    The Canadian Alliance for Monitoring Effectiveness and Safety of Antipsychotics in Children CAMESA Guideline Project
    J Can Acad Child Adolesc Psychiatry 20:218-33. 2011
    ..These medications have the potential to cause major metabolic and neurological complications with chronic use...
  13. doi request reprint Metabolic and neurological complications of second-generation antipsychotic use in children: a systematic review and meta-analysis of randomized controlled trials
    Tamara Pringsheim
    University of Calgary, Calgary, AB, Canada
    Drug Saf 34:651-68. 2011
    ..Given the demonstrated metabolic and neurological adverse effects seen in adult patients on these medications, detailed evaluation of the risk for these adverse effects in children is appropriate...
  14. doi request reprint Complications of antipsychotic therapy in children with tourette syndrome
    Tamara Pringsheim
    Department of Clinical Neurosciences and Pediatrics, University of Calgary, Calgary, Alberta, Canada
    Pediatr Neurol 43:17-20. 2010
    ..Neurologic complications are uncommon, which is likely attributable to the primary use of atypical antipsychotics in this setting...
  15. doi request reprint Prenatal and perinatal morbidity in children with Tourette syndrome and attention-deficit hyperactivity disorder
    Tamara Pringsheim
    Department of Clinical Neurosciences and Pediatrics, University of Calgary, Calgary, Alberta, Canada
    J Dev Behav Pediatr 30:115-21. 2009
    ..Low birth weight is a known risk factor for ADHD. The objective of the study was to assess the association between pre- and perinatal morbidity and the comorbid diagnosis of ADHD in children with TS...
  16. pmc Perspectives on neurological patient registries: a literature review and focus group study
    Lawrence Korngut
    Department of Clinical Neurosciences and Hotchkiss Brain Institute, University of Calgary, Clinical Neurosciences, South Health Campus, 4448 Front Street SE, Calgary, Alberta T3M 1M4, Canada
    BMC Med Res Methodol 13:135. 2013
    ..An examination and synthesis of registry stakeholder perspectives has not been previously reported in the literature...
  17. doi request reprint A systematic review and meta-analysis on the epidemiology of Duchenne and Becker muscular dystrophy
    Jean K Mah
    Department of Clinical Neurosciences, University of Calgary, Canada Department of Pediatrics, Alberta Children s Hospital Research Institute, University of Calgary, Canada Electronic address
    Neuromuscul Disord 24:482-91. 2014
    ..There is a need for more epidemiological studies addressing global estimates on incidence and prevalence of muscular dystrophies, utilizing standardized diagnostic criteria as well as multiple sources of case ascertainment. ..
  18. doi request reprint The pharmacoepidemiology of selective serotonin reuptake inhibitors for children and adolescents in Canada from 2005 to 2009: a database analysis
    Darren Lam
    Department of Clinical Neurosciences Psychiatry, and Pediatrics, University of Calgary, Canada
    Paediatr Drugs 15:319-27. 2013
    ..The aim of this study was to describe the frequency and trends in prescriptions and recommendations for selective serotonin reuptake inhibitors (SSRIs) for mental health disorders in children and adolescents in Canada from 2005 to 2009...
  19. pmc Recommendations for optimal ICD codes to study neurologic conditions: a systematic review
    Christine St Germaine-Smith
    Department of Clinical Neurosciences, University of Calgary, Canada
    Neurology 79:1049-55. 2012
    ..Administrative health data are frequently used for large population-based studies. However, the validity of these data for identifying neurologic conditions is uncertain...
  20. doi request reprint The prevalence of Parkinson's disease: A systematic review and meta-analysis
    Tamara Pringsheim
    Department of Clinical Neurosciences, University of Calgary, Alberta, Canada Hotchkiss Brain Institute, University of Calgary, Alberta, Canada Department of Community Health Sciences, University of Calgary, Alberta, Canada
    Mov Disord 29:1583-90. 2014
    ..05). PD prevalence increases steadily with age. Some differences in prevalence by geographic location and sex can be detected. © 2014 International Parkinson and Movement Disorder Society. ..
  21. ncbi request reprint Canadian Headache Society guideline for migraine prophylaxis
    Tamara Pringsheim
    University of Calgary and the Hotchkiss Brain Institute, Calgary, AB, Canada
    Can J Neurol Sci 39:S1-59. 2012
    ..This guideline is focused on patients with episodic migraine (headache on ≤ 14 days a month)...